Abstract: A middle air duct support member and an air conditioner provided. The middle air duct support member has an annular first support portion and an annular second support portion arranged at an axial end of the first support portion. The second support portion and the first support portion are manufactured separately.

Abstract: A farmland reference crop evapotranspiration prediction method based on uncertainty of meteorological factors, includes: S1. acquiring a set number of groups of weather forecast data of a prediction region within a preset time period; S2. inputting each group of weather forecast data into a Bayesian probability forecast system to obtain corrected weather forecast data; and S3. inputting each group of the corrected weather forecast data into a trained RBF neural network, and predicting to obtain a farmland reference crop evapotranspiration. In the present invention, the Bayesian probability forecast system is configured to correct the weather forecast data and eliminate uncertainty of weather forecast data to obtain the accurate reference crop evapotranspiration forecasted by the RBF neural network using these data.

Abstract: The present invention provides piperidin-4-yl azetidine derivatives, as well as their compositions and methods of use, that modulate the activity of Janus kinase 1 (JAK1) and are useful in the treatment of diseases related to the activity of JAK1 including, for example, inflammatory disorders, autoimmune disorders, cancer, and other diseases.

Abstract: An apparatus including a processor and a memory, where the processor and the memory are configured to provide a secure execution environment and the memory stores a hardware unique key and a class key. The processor is configured to recover, in the secure execution environment, a certificate signing key based on the class key, where the certificate signing key is associated with a certificate authority. The processor is further configured to derive a device key pair based on the hardware unique key, where the device key pair includes a device public key and a device private key, and generate a device certificate based on the device public key and the certificate signing key. The generated device certificate is configured to be validated based on a public key associated with the certificate authority.

Abstract: The present invention discloses a copper alloy, which includes: 5 wt % to 15 wt % of Zn, 0.2 wt % to 2.5 wt % of Sn, 0.1 wt % to 2.0 wt % of Ni, 0.01 wt % to 0.3 wt % of P, 0 to 0.3 wt % of Mg, 0 to 0.5 wt % of Fe, and a balance of Cu and inevitable impurities. Preferably, it is controlled that 1.0 wt %?Ni+Sn?3.5 wt %, the weight ratio of Ni to Sn is 0.08 to 10; the weight ratio of Ni to P is 2 to 15, Ni and P form a NiP compound in a matrix. During the crystal orientation analysis using EBSD measurement, the area in a Brass orientation {011}<211> at a derivation angle of less than 15° accounts for 10% to 25%. The yield strength 600 MPa, the electrical conductivity is ?25% IACS, and the bending machinability is excellent because the value R/t in a GW direction is ?1 and the value R/t in a BW direction is ?2.

Abstract: Some embodiments of the invention may include an eddy current nondestructive evaluation device. The eddy current nondestructive evaluation device may include a rotating body; a motor coupled with the rotating body such that the motor rotates the rotating body; a permanent magnet coupled with the rotating body; a pickup coil coupled with the rotating body; and an integrator circuit electrically coupled with the pickup coil that integrates a voltage from the pickup coil to produce integrated voltage data.

Abstract: A nanosecond pulser system is disclosed. In some embodiments, the nanosecond pulser system may include a nanosecond pulser having a nanosecond pulser input; a plurality of switches coupled with the nanosecond pulser input; one or more transformers coupled with the plurality of switches; and an output coupled with the one or more transformers and providing a high voltage waveform with a amplitude greater than 2 kV and a frequency greater than 1 kHz based on the nanosecond pulser input. The nanosecond pulser system may also include a control module coupled with the nanosecond pulser input; and an control system coupled with the nanosecond pulser at a point between the transformer and the output, the control system providing waveform data regarding an high voltage waveform produced at the point between the transformer and the output.

Abstract: This application relates to compounds of Formula (I): or pharmaceutically acceptable salts or stereoisomers thereof, which modulate the activity of adenosine receptors, such as subtypes A2A and A2B receptors, and are useful in the treatment of diseases related to the activity of adenosine receptors including, for example, cancer, inflammatory diseases, cardiovascular diseases, and neurodegenerative diseases.

Abstract: An air conditioner includes a housing. The housing includes a panel including an opening. The air conditioner further includes an indicator light arranged at the opening, an air heat exchange duct and an air treatment duct arranged in the housing and not in communication with each other, an air heat exchange device arranged at the air heat exchange duct and configured to conduct heat exchange for air in the air heat exchange duct, and an air treatment device arranged at the air treatment duct and configured to conduct at least one of humidification or purification for air in the air treatment duct.

Abstract: Some embodiments of the invention may include an eddy current nondestructive evaluation device. The eddy current nondestructive evaluation device may include a rotating body; a motor coupled with the rotating body such that the motor rotates the rotating body; a permanent magnet coupled with the rotating body; a pickup coil coupled with the rotating body; and an integrator circuit electrically coupled with the pickup coil that integrates a voltage from the pickup coil to produce integrated voltage data.

Abstract: A nanosecond pulser system is disclosed. In some embodiments, the nanosecond pulser system may include a nanosecond pulser having a nanosecond pulser input; a plurality of switches coupled with the nanosecond pulser input; one or more transformers coupled with the plurality of switches; and an output coupled with the one or more transformers and providing a high voltage waveform with a amplitude greater than 2 kV and a frequency greater than 1 kHz based on the nanosecond pulser input. The nanosecond pulser system may also include a control module coupled with the nanosecond pulser input; and an control system coupled with the nanosecond pulser at a point between the transformer and the output, the control system providing waveform data regarding an high voltage waveform produced at the point between the transformer and the output.

Abstract: Disclosed are combination therapies comprising administration of a CD73 inhibitor and an adenosine A2A or A2B receptor inhibitor. The disclosed combination therapies are useful in the treatment of diseases related to the activity of adenosine receptors and/or CD73 including, for example, cancer, inflammatory diseases, cardiovascular diseases, and neurodegenerative diseases. Anti-CD73 antibodies and A2A/A2B inhibitors are also disclosed.

Abstract: The present application provides methods of treating cancer using a combination of an inhibitor of A2A and/or A2B and an inhibitor of PD-1 and/or PD-L1.

Abstract: The present invention discloses a copper alloy, which includes: 5 wt % to 15 wt % of Zn, 0.2 wt % to 2.5 wt % of Sn, 0.1 wt % to 2.0 wt % of Ni, 0.01 wt % to 0.3 wt % of P, 0 to 0.3 wt % of Mg, 0 to 0.5 wt % of Fe, and a balance of Cu and inevitable impurities. Preferably, it is controlled that 1.0 wt %?Ni+Sn?3.5 wt %, the weight ratio of Ni to Sn is 0.08 to 10; the weight ratio of Ni to P is 2 to 15, Ni and P form a NiP compound in a matrix. During the crystal orientation analysis using EBSD measurement, the area in a Brass orientation {011}<211> at a derivation angle of less than 15° accounts for 10% to 25%. The yield strength 600 MPa, the electrical conductivity is ?25% IACS, and the bending machinability is excellent because the value R/t in a GW direction is ?1 and the value R/t in a BW direction is ?2.

Abstract: This application relates to compounds of Formula I: or pharmaceutically acceptable salts thereof, which are inhibitors of TAM kinases which are useful for the treatment of disorders such as cancer.

Abstract: This application relates to compounds of Formula (I): or pharmaceutically acceptable salts or stereoisomers thereof, which modulate the activity of adenosine receptors, such as subtypes A2A and A2B receptors, and are useful in the treatment of diseases related to the activity of adenosine receptors including, for example, cancer, inflammatory diseases, cardiovascular diseases, and neurodegenerative diseases.

Abstract: The invention is a copper alloy with excellent comprehensive performance, including the following components in percentage by weight: 0.4 wt %-2.0 wt % of Ni, 0.2 wt %-2.5 wt % of Sn, 0.02 wt %-0.25 wt % of P, 0.001 wt %-0.5 wt % of Si, and the balance of Cu and unavoidable impurities. The copper alloy has a yield strength of 550 MPa or above, and an electrical conductivity of 38% IACS or above. A bending workability is as follows: the value of R/t in the GW direction is less than or equal to 1, and the value of R/t in the BW direction is less than or equal to 2; and after the copper alloy is kept at 150° C. for 1000 hours, a residual stress rate is greater than or equal to 75%, and the stress relaxation resistance is excellent.

Abstract: Disclosed in the present invention is an application of (5R)-5-hydroxytriptolide in the preparation of drugs, in particular an application in the preparation of drugs for treating and/or preventing acquired immune deficiency syndrome (AIDS) abnormal immune activation or incomplete immune reconstitution associated with AIDS abnormal immune activation. The present invention uses (5R)-5-hydroxytriptolide (T8) in experiments and finds that (5R)-5-hydroxytriptolide has an immunosuppressive activity against AIDS abnormal immune activation or incomplete immune reconstitution associated with AIDS abnormal immune activation, is characterized by high efficiency and low toxicity, and has a good safety treatment index.

Abstract: The present invention provides piperidin-4-yl azetidine derivatives, as well as their compositions and methods of use, that modulate the activity of Janus kinase 1 (JAK1) and are useful in the treatment of diseases related to the activity of JAK1 including, for example, inflammatory disorders, autoimmune disorders, cancer, and other diseases.

Abstract: This application relates to compounds of Formula (I): or pharmaceutically acceptable salts thereof, which modulate the activity of adenosine receptors, such as subtypes A2A and A2B receptors, and are useful in the treatment of diseases related to the activity of adenosine receptors including, for example, cancer, inflammatory diseases, cardiovascular diseases, and neurodegenerative diseases.